| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.8M | — | +233.7% |
| Cost of Revenue | $4.1M | — | -49.5% |
| R&D Expense | $5.4M | — | +56.1% |
| SG&A Expense | $3.1M | — | +17.2% |
| Operating Income | $21.1M | — | +610.2% |
| Pre-tax Income | $21.1M | — | +666.5% |
| Income Tax | $2.8M | — | +2599.1% |
| Net Income | $18.3M | — | +606.1% |
| EPS (Basic) | $0.23 | — | +560.0% |
| EPS (Diluted) | $0.22 | — | +540.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.0M | +179.3% | +110.7% |
| Accounts Receivable | $2.9M | -66.8% | -37.1% |
| Inventory | $30.5M | +18.4% | +56.2% |
| Current Assets | $86.4M | +29.5% | +42.7% |
| Total Assets | $102.3M | +24.3% | +38.5% |
| Current Liabilities | $27.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $22.0M | — | +535.4% |
| Capital Expenditures | $761K | — | +148.7% |
| Investing Cash Flow | $4.2M | — | +1453.5% |
| Financing Cash Flow | $150K | — | -97.0% |
| Free Cash Flow | $21.3M | — | +496.4% |
| +12.6% |
| Total Liabilities | $35.1M | +2.9% | +22.4% |
| Stockholders' Equity | $67.2M | +39.4% | +48.7% |